Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Shida

Showing results (151-160 of 158) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 158 results.
The Journal of Experimental Medicine|May 19, 1997
CXCR4/fusin is not a species-specific barrier in murine cells for HIV-1 entryK Tachibana, T Nakajima, A Sato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1995
[A case of multiple liver metastasis from remnant gastric cancer responding to leucovorin.5-FU+UFT therapy]M Matsumoto, T Machida, H Higashi, et al.
Journal of Virology|December 1, 1988
Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope geneH Shida, Y Hinuma, M Hatanaka, et al.
Virology|December 1, 1996
Identification of HTLV-1-specific CTL directed against synthetic and naturally processed peptides in HLA-B*3501 transgenic miceC Schönbach, K Nokihara, C R Bangham, et al.
Lupus|June 30, 2017
Effects of statins on thrombosis development in patients with systemic lupus erythematosus and antiphospholipid antibodiesT Watanabe, K Oku, O Amengual, et al.
Journal of Virology|December 16, 1998
Determinant in human immunodeficiency virus type 1 for efficient replication under cytokine-induced CD4(+) T-helper 1 (Th1)- and Th2-type conditionsY Suzuki, Y Koyanagi, Y Tanaka, et al.
FEBS Letters|September 22, 1998
Intracellular localization and release of eotaxin from normal eosinophilsT Nakajima, H Yamada, M Iikura, et al.
Journal of Virology|August 10, 1999
Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infectionT Murakami, T Y Zhang, Y Koyanagi, et al.
Pageof 16

Showing results (151-160 of 158) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 158 results.
The Journal of Experimental Medicine|May 19, 1997
CXCR4/fusin is not a species-specific barrier in murine cells for HIV-1 entryK Tachibana, T Nakajima, A Sato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1995
[A case of multiple liver metastasis from remnant gastric cancer responding to leucovorin.5-FU+UFT therapy]M Matsumoto, T Machida, H Higashi, et al.
Journal of Virology|December 1, 1988
Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope geneH Shida, Y Hinuma, M Hatanaka, et al.
Virology|December 1, 1996
Identification of HTLV-1-specific CTL directed against synthetic and naturally processed peptides in HLA-B*3501 transgenic miceC Schönbach, K Nokihara, C R Bangham, et al.
Lupus|June 30, 2017
Effects of statins on thrombosis development in patients with systemic lupus erythematosus and antiphospholipid antibodiesT Watanabe, K Oku, O Amengual, et al.
Journal of Virology|December 16, 1998
Determinant in human immunodeficiency virus type 1 for efficient replication under cytokine-induced CD4(+) T-helper 1 (Th1)- and Th2-type conditionsY Suzuki, Y Koyanagi, Y Tanaka, et al.
FEBS Letters|September 22, 1998
Intracellular localization and release of eotaxin from normal eosinophilsT Nakajima, H Yamada, M Iikura, et al.
Journal of Virology|August 10, 1999
Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infectionT Murakami, T Y Zhang, Y Koyanagi, et al.
Pageof 16